Home » Stocks » SIBN

SI-BONE, Inc. (SIBN)

Stock Price: $31.20 USD 0.60 (1.96%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 1.01B
Revenue (ttm) 71.05M
Net Income (ttm) -43.82M
Shares Out 28.71M
EPS (ttm) -1.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $31.20
Previous Close $30.60
Change ($) 0.60
Change (%) 1.96%
Day's Open 30.39
Day's Range 30.00 - 31.23
Day's Volume 254,920
52-Week Range 8.36 - 31.23

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 2 weeks ago

Laura Francis to Become Chief Executive Officer; Jeff Dunn to Become Executive Chairman;  and Tony Recupero to Become President.

GlobeNewsWire - 1 month ago

Updated Blue Cross Blue Shield Association Evidence Rating Supports only Triangular Implants Updated Blue Cross Blue Shield Association Evidence Rating Supports only Triangular Implants

GlobeNewsWire - 1 month ago

SANTA CLARA, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today a...

GlobeNewsWire - 1 month ago

Humana is one of the 5 largest commercial payors in the U.S. and joins 36 other commercial health plans that offer coverage for the triangular iFuse Implant System only Humana is one of the 5 ...

Seeking Alpha - 2 months ago

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

SANTA CLARA, Calif. , Nov. 02, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today r...

Zacks Investment Research - 2 months ago

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 3 months ago

SANTA CLARA, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today a...

GlobeNewsWire - 3 months ago

SANTA CLARA, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices...

GlobeNewsWire - 3 months ago

SANTA CLARA, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices...

GlobeNewsWire - 3 months ago

SANTA CLARA, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today an...

GlobeNewsWire - 3 months ago

SANTA CLARA, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacrop...

GlobeNewsWire - 4 months ago

SANTA CLARA, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, anno...

GlobeNewsWire - 4 months ago

SANTA CLARA, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, toda...

Zacks Investment Research - 4 months ago

SI-BONE is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

GlobeNewsWire - 4 months ago

35 U.S. payers now cover iFuse exclusively 35 U.S. payers now cover iFuse exclusively

Seeking Alpha - 5 months ago

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Si-Bone (SIBN) delivered earnings and revenue surprises of 31.25% and 48.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

SANTA CLARA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today ...

GlobeNewsWire - 5 months ago

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...

Zacks Investment Research - 5 months ago

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 6 months ago

SANTA CLARA, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...

GlobeNewsWire - 7 months ago

SANTA CLARA, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacr...

GlobeNewsWire - 7 months ago

New positive coverage policy further validates acceptance of iFuse as an important treatment option for patients with chronic sacroiliac joint dysfunction

Seeking Alpha - 8 months ago

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Si-Bone (SIBN) delivered earnings and revenue surprises of -30.56% and -6.45%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 8 months ago

SANTA CLARA, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today r...

Zacks Investment Research - 8 months ago

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 10 months ago

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 1 year ago

New positive coverage policy is specific for FDA cleared implants placed across the SI joint and intended to promote bone fusion New positive coverage policy is specific for FDA cleared implan...

GlobeNewsWire - 1 year ago

SANTA CLARA, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacr...

Seeking Alpha - 1 year ago

SI-BONE, Inc.'s (SIBN) CEO Jeff Dunn on Q3 2019 Results - Earnings Call Transcript

GlobeNewsWire - 1 year ago

Long-term follow-up results show excellent durability of clinical responses and positive radiographic outcomes for SI joint fusion using triangular titanium implants Long-term follow-up result...

GlobeNewsWire - 1 year ago

SANTA CLARA, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...

Seeking Alpha - 1 year ago

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

SI-BONE's (SIBN) CEO Jeff Dunn on Q1 2019 Results - Earnings Call Transcript

About SIBN

SI-BONE, a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was founded in 2008 and is headquartered in Santa Clara, California.

Industry
Medical Devices
IPO Date
Oct 17, 2018
CEO
Jeffrey Dunn
Employees
262
Stock Exchange
NASDAQ
Ticker Symbol
SIBN
Full Company Profile

Financial Performance

In 2019, SI-BONE, Inc.'s revenue was $67.30 million, an increase of 21.53% compared to the previous year's $55.38 million. Losses were -$38.40 million, 120.0% more than in 2018.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for SI-BONE, Inc. stock is "Strong Buy." The 12-month stock price forecast is 34.29, which is an increase of 9.90% from the latest price.

Price Target
$34.29
(9.90% upside)
Analyst Consensus: Strong Buy